PATENT CLAIM ANALYSIS

Application Number: 16111721
Application Type: Utility
Filing Date: 2018-08
Publication Date: 2018-12
Patent Classification: ["514", "423000"]

Abstract:
The invention relates to a compound of formula (I) wherein R 1  and R 2  are defined as in the description and in the claims. The compound of formula (I) can be used as a medicament.

Claim (Index 13):
The use of a compound according to any one of  claims 1  to  8  for the preparation of medicaments for the treatment or prophylaxis of diabetes, atherosclerosis, abdominal aortic aneurysm, peripheral arterial disease, cancer, reduction of cardiovascular events in chronic kidney disease, diabetic nephropathy, diabetic rethinopathy or age related macular degeneration.

Metadata:
- Claim Count in Document: 2.0
- Percentile: 96.0
- Lexical Diversity: 1.5
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: True
- Related Applications: ['12761427', '13767031', '13760519', '14648418', '12791914']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7939172977686334
- 35 USC 102 Novelty (BERT): 0.5630306414693195
- Combined Prediction Score: 0.770828632138702
- Mean Citation Score: 392.150816
- Max Citation Score: 440.72263
- Similarity Product: 329.2628504440766

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test